Australia markets closed

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
22.48+1.63 (+7.82%)
At close: 04:00PM EDT
22.60 +0.12 (+0.53%)
After hours: 07:49PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts12121212
Avg. Estimate-0.72-0.7-2.63-2.05
Low estimate-0.82-0.87-3.31-3.02
High estimate-0.65-0.43-1.44-0.54
Year ago EPS-0.82-0.75-2.92-2.63
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts9101212
Avg. EstimateN/A4.39M26.29M154.61M
Low estimateN/AN/A800k23.1M
High estimateN/A24.23M100.33M313M
Year ago salesN/AN/AN/A26.29M
Sales growth (year/est)N/AN/AN/A488.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.79-0.81-0.79-0.68
Actual EPS-0.82-0.75-0.64-0.66
Difference-0.030.060.150.02
Surprise %-3.80%7.40%19.00%2.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.72-0.7-2.63-2.05
7 days ago-0.72-0.7-2.63-2.05
30 days ago-0.72-0.7-2.63-1.98
60 days ago-0.7-0.71-2.65-1.84
90 days ago-0.71-0.72-2.75-1.88
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRCKTIndustrySector(s)S&P 500
Current qtr.12.20%N/AN/AN/A
Next qtr.6.70%N/AN/AN/A
Current year9.90%N/AN/AN/A
Next year22.10%N/AN/AN/A
Next 5 years (per annum)41.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A